Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic LeukemiaPeter Hillmen, Jiřı́ Mayer, Tadeusz Robak et al.|Journal of Clinical Oncology|2007Cited by 556
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Barbara D. Alexander, Francisco M. Marty et al.|Clinical Infectious Diseases|2021Cited by 299